THR-123

SLU-PP-332 is a small synthetic molecule, not a peptide, that turns on the estrogen-related receptors (ERRalpha, beta and gamma), the master switches behind much of the body's response to endurance exercise. Researchers call it an 'exercise mimetic' because in mice it boosts mitochondria, shifts muscle toward fatigue-resistant fibers, improves stamina and trims fat without the animal moving more. It was made as a lab tool to study exercise biology. There are no human trials.

Pancragen is a synthetic tetrapeptide bioregulator, Lys-Glu-Asp-Trp (KEDW), from the Khavinson group, designed to target pancreatic tissue. It is studied for supporting blood-sugar control and the insulin-producing endocrine pancreas, especially in aging. It is a research compound with no approval and no published human clinical trials. The notable evidence comes from aged primates, not people.

KLOW is a four-peptide blend that adds KPV to the GLOW mix, so it contains GHK-Cu, BPC-157, TB-500, and KPV. It is marketed for healing, anti-inflammatory, and skin and gut benefits, typically sold as a single research vial (commonly around 80 mg total). As with the other blends, none of the peptides is FDA-approved for these uses, and the KLOW combination has never been tested as a product in a clinical trial.

KPV is a tiny tripeptide, just three amino acids (lysine, proline, valine), that forms the tail end of the natural hormone alpha-MSH. It is studied almost entirely as an anti-inflammatory agent, particularly for gut and skin inflammation. There are no registered human clinical trials proving its benefits in people; the evidence base is cell-culture and animal studies, so anything you read about it treating disease is preliminary.

Thymosin beta-4 (Tbeta4) is a small 43 amino acid peptide found in nearly every cell in the body, originally isolated from the thymus. Its main job is binding and sequestering G-actin, the building block of the cell's internal scaffolding, which lets it influence cell movement, wound repair, and tissue regeneration. It is researched heavily for healing of skin, cornea, and heart tissue, but it is not an FDA-approved drug. (The injectable sold as TB-500 is a synthetic fragment marketed as related to Tbeta4, not the full natural peptide.)

Chonluten is a synthetic tripeptide (Glu-Asp-Gly, EDG) from the Khavinson bioregulator family, pitched as the lung and bronchial peptide, derived conceptually from the same program that produced Epitalon and Cortagen. It is researched for respiratory tissue and age-related lung decline, and it has no FDA or EMA approval. The evidence is essentially all preclinical or uncontrolled Russian clinical observation, with no randomized human trials.